articleThe Lancet OncologyApr 29, 2013Closed access

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study

National Hospital Organization Kyushu Cancer Center · Okayama University · +14 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding